Glenmark gets interim order vs. Napo
MUMBAI (Reuters) - Glenmark Pharmaceuticals Ltd said on Friday it had received an interim order from a U.S. arbitration panel against U.S.-based Napo Pharamaceuticals Inc's termination of a Collaboration pact for an HIV-associated diarrhoea drug. The pact, signed in July 2005, had conferred exclusive rights to Glenmark to develop, commercialize and distribute the drug, Crofelemer, in 140 countries. The move provides interim relief to Glenmark, which recently started trials of the drug to treat cases of adult acute diarrhoea, including cholera. ... read more..
source:yahoo.com
No comments:
Post a Comment